Genetic analysis of the FBXO48 gene in Chinese Han patients with Parkinson disease

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 224-226

  Xiu, Xiaofei ^a   Song, Zhi ^a   Gao, Kai ^a   Deng, Xiong ^a   Qi, Yong ^a   Zhu, Anding ^a   Gong, Lina ^a   Deng, Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Coding region; FBXO48; FBXO7; PARK3; Parkinson disease

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL FEATURE; DNA SCREENING; F BOX ONLY PROTEIN 48 GENE; FEMALE; GENE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; F-BOX PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84876419007     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.02.031     Document Type: Article

References (23)

1. Beal M.F. Parkinson's disease: a model dilemma. Nature 2010, 466:S8-S10.
2. Corti O., Lesage S., Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol. Rev. 2011, 91:1161-1218.
3. Davison C. Pallido-pyramidal disease. J. Neuropathol. Exp. Neurol. 1954, 13:50-59.
4. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
5. Deng H., Liang H., Jankovic J. F-box only protein 7 gene in Parkinsonian-pyramidal disease. Arch. Neurol. 2012, 1-5.
6. DeStefano A.L., Lew M.F., Golbe L.I., Mark M.H., Lazzarini A.M., Guttman M., Montgomery E., Waters C.H., Singer C., Watts R.L., Currie L.J., Wooten G.F., Maher N.E., Wilk J.B., Sullivan K.M., Slater K.M., Saint-Hilaire M.H., Feldman R.G., Suchowersky O., Lafontaine A.L., Labelle N., Growdon J.H., Vieregge P., Pramstaller P.P., Klein C., Hubble J.P., Reider C.R., Stacy M., MacDonald M.E., Gusella J.F., Myers R.H. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am. J. Hum. Genet. 2002, 70:1089-1095.
7. Gasser T., Muller-Myhsok B., Wszolek Z.K., Oehlmann R., Calne D.B., Bonifati V., Bereznai B., Fabrizio E., Vieregge P., Horstmann R.D. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet. 1998, 18:262-265.
8. Guo Y., Deng X., Zheng W., Xu H., Song Z., Liang H., Lei J., Jiang X., Luo Z., Deng H. HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease. Neurosci. Lett. 2011, 501:185-187.
9. Hardy J. Genetic analysis of pathways to Parkinson disease. Neuron 2010, 68:201-206.
10. Ilyin G.P., Rialland M., Pigeon C., Guguen-Guillouzo C. cDNA cloning and expression analysis of new members of the mammalian F-box protein family. Genomics 2000, 67:40-47.
11. Jankovic J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008, 79:368-376.
12. Karamohamed S., DeStefano A.L., Wilk J.B., Shoemaker C.M., Golbe L.I., Mark M.H., Lazzarini A.M., Suchowersky O., Labelle N., Guttman M., Currie L.J., Wooten G.F., Stacy M., Saint-Hilaire M., Feldman R.G., Sullivan K.M., Xu G., Watts R., Growdon J., Lew M., Waters C., Vieregge P., Pramstaller P.P., Klein C., Racette B.A., Perlmutter J.S., Parsian A., Singer C., Montgomery E., Baker K., Gusella J.F., Fink S.J., Myers R.H., Herbert A. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology 2003, 61:1557-1561.
13. Lei J., Deng X., Zhang J., Su L., Xu H., Liang H., Huang X., Song Z., Deng H. Mutation screening of the HDC gene in Chinese Han patients with Tourette syndrome. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2012, 159B:72-76.
14. Liang H., Zheng W., Xu H., Lei J., Song Z., Jiang X., Zeng Z., Deng H. No evidence of association between the LINGO4 gene and essential tremor in Chinese Han patients. Parkinsonism Relat. Disord. 2012, 18:303-305.
15. Lill C.M., Roehr J.T., McQueen M.B., Kavvoura F.K., Bagade S., Schjeide B.M., Schjeide L.M., Meissner E., Zauft U., Allen N.C., Liu T., Schilling M., Anderson K.J., Beecham G., Berg D., Biernacka J.M., Brice A., DeStefano A.L., Do C.B., Eriksson N., Factor S.A., Farrer M.J., Foroud T., Gasser T., Hamza T., Hardy J.A., Heutink P., Hill-Burns E.M., Klein C., Latourelle J.C., Maraganore D.M., Martin E.R., Martinez M., Myers R.H., Nalls M.A., Pankratz N., Payami H., Satake W., Scott W.K., Sharma M., Singleton A.B., Stefansson K., Toda T., Tung J.Y., Vance J., Wood N.W., Zabetian C.P., Young P., Tanzi R.E., Khoury M.J., Zipp F., Lehrach H., Ioannidis J.P., Bertram L. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 2012, 8:e1002548.
16. Polymeropoulos M.H., Higgins J.J., Golbe L.I., Johnson W.G., Ide S.E., Di Iorio G., Sanges G., Stenroos E.S., Pho L.T., Schaffer A.A., Lazzarini A.M., Nussbaum R.L., Duvoisin R.C. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996, 274:1197-1199.
17. Sharma M., Maraganore D.M., Ioannidis J.P., Riess O., Aasly J.O., Annesi G., Abahuni N., Bentivoglio A.R., Brice A., Van Broeckhoven C., Chartier-Harlin M.C., Destee A., Djarmati A., Elbaz A., Farrer M., Ferrarese C., Gibson J.M., Gispert S., Hattori N., Jasinska-Myga B., Klein C., Lesage S., Lynch T., Lichtner P., Lambert J.C., Lang A.E., Mellick G.D., De Nigris F., Opala G., Quattrone A., Riva C., Rogaeva E., Ross O.A., Satake W., Silburn P.A., Theuns J., Toda T., Tomiyama H., Uitti R.J., Wirdefeldt K., Wszolek Z., Gasser T., Kruger R. Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Neurobiol. Aging 2011, 32:2101-2108.
18. Sharma M., Mueller J.C., Zimprich A., Lichtner P., Hofer A., Leitner P., Maass S., Berg D., Durr A., Bonifati V., De Michele G., Oostra B., Brice A., Wood N.W., Muller-Myhsok B., Gasser T. The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations. J. Med. Genet. 2006, 43:557-562.
19. Shojaee S., Sina F., Banihosseini S.S., Kazemi M.H., Kalhor R., Shahidi G.A., Fakhrai-Rad H., Ronaghi M., Elahi E. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500K SNP arrays. Am. J. Hum. Genet. 2008, 82:1375-1384.
20. Takazawa C., Fujimoto K., Homma D., Sumi-Ichinose C., Nomura T., Ichinose H., Katoh S. A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice - as a mouse model for Parkinson's disease. Biochem. Biophys. Res. Commun. 2008, 367:787-792.
21. Tobin J.E., Cui J., Wilk J.B., Latourelle J.C., Laramie J.M., McKee A.C., Guttman M., Karamohamed S., DeStefano A.L., Myers R.H. Sepiapterin reductase expression is increased in Parkinson's disease brain tissue. Brain Res. 2007, 1139:42-47.
22. West A.B., Zimprich A., Lockhart P.J., Farrer M., Singleton A., Holtom B., Lincoln S., Hofer A., Hill L., Muller-Myhsok B., Wszolek Z.K., Hardy J., Gasser T. Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur. J. Hum. Genet. 2001, 9:659-666.
23. Zimprich A., Benet-Pages A., Struhal W., Graf E., Eck S.H., Offman M.N., Haubenberger D., Spielberger S., Schulte E.C., Lichtner P., Rossle S.C., Klopp N., Wolf E., Seppi K., Pirker W., Presslauer S., Mollenhauer B., Katzenschlager R., Foki T., Hotzy C., Reinthaler E., Harutyunyan A., Kralovics R., Peters A., Zimprich F., Brucke T., Poewe W., Auff E., Trenkwalder C., Rost B., Ransmayr G., Winkelmann J., Meitinger T., Strom T.M. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 2011, 89:168-175.